These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 197423)

  • 21. Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.
    Lloyd KG; Hornykiewics O
    Life Sci; 1977 Nov; 21(10):1489-96. PubMed ID: 927011
    [No Abstract]   [Full Text] [Related]  

  • 22. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
    Starr MS
    Neurosci Lett; 1980 May; 18(1):79-84. PubMed ID: 6133247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra.
    van der Heyden JA; Venema K; Korf J
    J Neurochem; 1980 Jan; 34(1):119-25. PubMed ID: 6778956
    [No Abstract]   [Full Text] [Related]  

  • 24. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential sensitivity of presumed dopaminergic and non-dopaminergic neurones in rat substantia nigra to electrophoretically applied substance P.
    Pinnock RD; Dray A
    Neurosci Lett; 1982 Apr; 29(2):153-8. PubMed ID: 6178059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
    Gale K
    Nature; 1980 Feb; 283(5747):569-70. PubMed ID: 7354838
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat.
    Torrens Y; Beaujouan JC; Besson MJ; Michelot R; Glowinski J
    Eur J Pharmacol; 1981 May; 71(4):383-92. PubMed ID: 6166487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
    Zivkovic B; Oblin A; Bartholini G
    Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata.
    Miyazaki T; Lacey MG
    J Physiol; 1998 Dec; 513 ( Pt 3)(Pt 3):805-17. PubMed ID: 9824719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zetidoline blocks dopamine autoreceptors in the rat substantia nigra.
    Harris NC; Pinnock RD; Woodruff GN
    Neuropharmacology; 1985 Jan; 24(1):33-6. PubMed ID: 2858831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D4 and D1 dopamine receptors modulate [3H] GABA release in the substantia nigra pars reticulata of the rat.
    Acosta-García J; Hernández-Chan N; Paz-Bermúdez F; Sierra A; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2009 Dec; 57(7-8):725-30. PubMed ID: 19715708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro.
    Starr MS
    Eur J Pharmacol; 1979 Jan; 53(3):215-26. PubMed ID: 759200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potassium-induced release of [3H] GABA and of [3H] noradrenaline from normal and reserpinized rat brain cortex slices, Differences in calcium-dependency, and in sensitivity to potassium ions.
    Vargas O; de Lorenzo MD; Saldate MC; Orrego F
    J Neurochem; 1977 Jan; 28(1):165-70. PubMed ID: 833590
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrically induced, calcium-dependent release of endogenous GABA from rat brain cortex slices.
    Valdés F; Orrego F
    Brain Res; 1978 Feb; 141(2):357-63. PubMed ID: 626907
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
    Jessell TM; Iversen LL
    Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
    [No Abstract]   [Full Text] [Related]  

  • 37. Topographical study of the distribution of gamma-aminobutyric acid (GABA) in the human substantia nigra. A case study.
    Kanazawa I; Toyokura Y
    Brain Res; 1975 Dec; 100(2):371-81. PubMed ID: 1192182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotational behaviour following inhibition of GABA metabolism unilaterally in the rat substantia nigra.
    Dray ; Oakley NR; Simmonds MA
    J Pharm Pharmacol; 1975 Aug; 27(8):627-9. PubMed ID: 239186
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigation of possible interactions between substance P and transmitter mechanisms in the substantia nigra and corpus striatum of the rat.
    Starr MS
    J Pharm Pharmacol; 1978 Jun; 30(6):359-63. PubMed ID: 26766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons.
    Caputi L; Bengtson CP; Guatteo E; Bernardi G; Mercuri NB
    Synapse; 2003 Mar; 47(3):236-9. PubMed ID: 12494406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.